Document Detail

Enhanced anaphylatoxin and terminal C5b-9 complement complex formation in patients with the syndrome of hemolysis, elevated liver enzymes, and low platelet count.
MedLine Citation:
PMID:  2216207     Owner:  NLM     Status:  MEDLINE    
Complement activation was studied in ten consecutive pregnant women developing hemolysis, elevated liver enzymes, and low platelet count (HELLP syndrome) and ten other women with normal pregnancies. Blood samples for anaphylatoxin (C3a/C3a desArg and C5a/C5a desArg) and terminal C5b-9 complement complex determinations were drawn at delivery and 24 hours and 7 days later. Women developing HELLP syndrome had higher plasma levels of anaphylatoxins with delivery than did women with uneventful pregnancies. The plasma levels of terminal C5b-9 complement complexes at the time of delivery were increased as compared with levels 1 and 7 days after delivery in women with HELLP syndrome. The plasma concentrations of the anaphylatoxins and the terminal C5b-9 complement complexes returned to normal levels within 1 week after delivery in the HELLP group. The formation of C5b-9 complement complex indicates that the terminal part of the complement cascade has been activated and that C5a has been formed and eliminated. Complement activation with release of anaphylatoxins and terminal C5b-9 complement complexes may be one etiologic factor behind the elevated blood pressure, hemolysis, liver insufficiency, and platelet consumption seen in these patients.
M Haeger; M Unander; A Bengtsson
Related Documents :
18516817 - Misoprostol and pregnancy: risk of malformations.
18774567 - Sublingual misoprostol after surgical management of early termination of pregnancy.
2694737 - Ru 486 (mifepristone): clinical trials in china.
2619027 - Prophylactic analgesia for daycase termination of pregnancy. a double-blind study with ...
17028507 - Maternal use of selective serotonin reuptake inhibitors and risk of congenital malforma...
9681097 - Drug and environmental factors associated with adverse pregnancy outcomes. part i: anti...
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't    
Journal Detail:
Title:  Obstetrics and gynecology     Volume:  76     ISSN:  0029-7844     ISO Abbreviation:  Obstet Gynecol     Publication Date:  1990 Oct 
Date Detail:
Created Date:  1990-11-02     Completed Date:  1990-11-02     Revised Date:  2009-10-26    
Medline Journal Info:
Nlm Unique ID:  0401101     Medline TA:  Obstet Gynecol     Country:  UNITED STATES    
Other Details:
Languages:  eng     Pagination:  698-702     Citation Subset:  AIM; IM    
Department of Obstetrics and Gynecology, Sahlgren Hospital, Göteborg, Sweden.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Alanine Transaminase / blood*
Anaphylatoxins / immunology*
Aspartate Aminotransferases / blood*
Complement Activation / immunology
Complement Membrane Attack Complex / immunology*
Hemolysis / immunology*
Platelet Count
Pre-Eclampsia / immunology*
Reg. No./Substance:
0/Anaphylatoxins; 0/Complement Membrane Attack Complex; EC Aminotransferases; EC Transaminase

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Prenatal administration of indomethacin as a tocolytic agent: effect on neonatal renal function.
Next Document:  Correlation between first- and early third-trimester glucose screening test results.